Quigg R J, He C, Hack B K, Alexander J J, Morgan B P
Department of Medicine, Section of Nephrology, The University of Chicago, Chicago, IL 60637, USA.
Immunology. 2000 Jan;99(1):46-53. doi: 10.1046/j.1365-2567.2000.00945.x.
Crry (CR1-related gene/protein) is a rodent complement regulator that inhibits C3 convertases. CD59 is a conserved protein inhibitor active towards C8 and C9. We have previously produced rat Crry as a recombinant soluble (rs) protein in Pichia pastoris. In this study we produced functionally active rat rsCD59 and a chimeric rsCD59-Crry protein in P. pastoris. The GPI anchor addition site of rat CD59 (Asn-79) was replaced either by a stop codon to produce rsCD59, or with the sequence of the first five short consensus repeats of Crry to produce rsCD59-Crry. Proteins were generated by fermentation and purified by affinity chromatography on an anti-CD59 column. In a standard classical pathway haemolysis assay, all three rs proteins had inhibitory activity, with 50% inhibition at 0.5 microM (rsCrry and rsCD59-Crry) and 4.4 microM (rsCD59). In an assay examining inhibition of C5b-9, in which C5b-7 was first formed, followed by purified C8 and C9, rsCD59 and rsCD59-Crry were active with 50% inhibition at 0.8 microM (rsCD59-Crry) and 1.3 microM (rsCD59). The degree of inhibition was independent of whether the C8 and C9 were of rat or human origin. Therefore, we have produced rsCD59 and rsCD59-Crry in P. pastoris. The rsCD59 retains its inhibitory activity towards C5b-9, while rsCD59-Crry appears to have the combined activities of Crry and CD59. In a haemolytic assay, the inclusion of CD59 to Crry is of no additional benefit to Crry, which may illustrate the overall importance of the C3 convertase step. Yet, inclusion of Crry to CD59 increases the potency of CD59 towards C5b-9.
Crry(CR1相关基因/蛋白)是一种抑制C3转化酶的啮齿动物补体调节因子。CD59是一种对C8和C9有活性的保守蛋白抑制剂。我们之前已在毕赤酵母中制备出大鼠Crry作为重组可溶性(rs)蛋白。在本研究中,我们在毕赤酵母中制备了具有功能活性的大鼠rsCD59和嵌合rsCD59-Crry蛋白。大鼠CD59的糖基磷脂酰肌醇(GPI)锚定添加位点(Asn-79)要么被终止密码子取代以产生rsCD59,要么被Crry的前五个短共有重复序列取代以产生rsCD59-Crry。通过发酵产生蛋白,并在抗CD59柱上通过亲和层析进行纯化。在标准经典途径溶血试验中,所有三种rs蛋白均具有抑制活性,rsCrry和rsCD59-Crry在0.5微摩尔时抑制率达50%,rsCD59在4.4微摩尔时抑制率达50%。在一项检测对C5b-9抑制作用的试验中,先形成C5b-7,随后加入纯化的C8和C9,rsCD59和rsCD59-Crry具有活性,rsCD59-Crry在0.8微摩尔时抑制率达50%,rsCD59在1.3微摩尔时抑制率达50%。抑制程度与C8和C9是大鼠来源还是人来源无关。因此,我们已在毕赤酵母中制备出rsCD59和rsCD59-Crry。rsCD59保留了其对C5b-9的抑制活性,而rsCD59-Crry似乎具有Crry和CD59的联合活性。在溶血试验中,在Crry中加入CD59对Crry并无额外益处,这可能说明了C3转化酶步骤的总体重要性。然而,在CD59中加入Crry会增加CD59对C5b-9的效力。